Doximity, Inc. (DOCS)

NYSE: DOCS · Real-Time Price · USD
57.33
-1.42 (-2.42%)
Aug 1, 2025, 4:00 PM - Market closed
-2.42%
Market Cap10.74B
Revenue (ttm)570.40M
Net Income (ttm)223.19M
Shares Out 187.42M
EPS (ttm)1.11
PE Ratio51.65
Forward PE39.58
Dividendn/a
Ex-Dividend Daten/a
Volume1,489,320
Open57.09
Previous Close58.75
Day's Range56.33 - 58.16
52-Week Range25.00 - 85.21
Beta1.36
AnalystsBuy
Price Target64.41 (+12.35%)
Earnings DateAug 7, 2025

About DFS

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]

Sector Healthcare
IPO Date Jun 24, 2021
Employees 830
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2024, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.

Financial numbers in GBP Financial Statements

Analyst Summary

According to 17 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $64.41, which is an increase of 12.35% from the latest price.

Price Target
$64.41
(12.35% upside)
Analyst Consensus: Buy
Stock Forecasts

News

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...

3 days ago - Business Wire

Doximity: Slowing Sales And EBITDA Growth

Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...

11 days ago - Seeking Alpha

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...

17 days ago - Business Wire

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certai...

25 days ago - GlobeNewsWire

Doximity Crushes The Rule Of 40 - Try Rule Of 58

I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...

4 weeks ago - Seeking Alpha

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...

6 weeks ago - Seeking Alpha

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...

2 months ago - Business Wire

Doximity Stock 7.8% Higher After Key Trading Signal

DOCS reverses steep decline after TradePulse Alert

2 months ago - Benzinga

These Analysts Cut Their Forecasts On Doximity After Q4 Results

Doximity, Inc. DOCS reported better-than-expected earnings for the fourth quarter on Thursday.

2 months ago - Benzinga

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.

Other symbols: AMATGLOB
2 months ago - Benzinga

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Fo...

2 months ago - Seeking Alpha

Doximity Stock Drops 20% After Outlook Disappoints

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

2 months ago - Investopedia

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ende...

2 months ago - Business Wire

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained m...

3 months ago - Seeking Alpha

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ...

3 months ago - Business Wire

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...

5 months ago - Business Wire

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y grow...

6 months ago - Seeking Alpha

Doximity Momentum, Big Money Support Stays Strong

Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

6 months ago - FXEmpire

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th ...

6 months ago - Business Wire

Doximity Q3 Earnings: Outpacing Even Management's Expectations

I previously rated Doximity, Inc. a buy due to strong Q2 earnings, favorable DCF analysis, and its strategic position in the healthcare industry. Q3 earnings showed continued strength, with DOCS stock...

6 months ago - Seeking Alpha

Digital Health Platform Doximity Stock Jumps On Upbeat Annual Outlook, Analysts Raise Forecast

Doximity Inc DOCS stock is trading higher on Friday after the company reported third-quarter fiscal 2025 results that beat analysts' expectations and upbeat guidance.

6 months ago - Benzinga

Doximity shares pop 30% on revenue beat, rosy guidance

Doximity shares ripped higher Friday, a day after reporting fiscal third-quarter results that beat expectations for revenue and guidance. Analysts called it a "statement type of quarter" for the compa...

6 months ago - CNBC

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

6 months ago - Seeking Alpha

Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance

Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance. The company's revenue increased 25% to $168.6 million in its third quarter.

6 months ago - CNBC

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the V...

6 months ago - Business Wire